GlassScriptPhysician profile
Lamont W Hornbeck
NPI 1871522664
$1,767.00
in general payments reported to CMS, 2019-2025
18 companies · $16.33 in 2025
The $16.33 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $59.36 · 2021: $131 · 2022: $344 · 2023: $61.23 · 2024: $245 · 2025: $16.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225 · Education: $98.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.55 |
| Education | $98.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $500.21 | 2019-2024 | |
| Janssen Biotech, INC. | $194.18 | 2022-2025 | Tremfya |
| Amgen INC. | $168.96 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $161.75 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $124.65 | 2019 | |
| Dusa Pharmaceuticals, INC. | $123.98 | 2019 | |
| Genentech USA, INC. | $95.48 | 2019-2020 | |
| Lilly USA, LLC | $90.80 | 2021-2022 | |
| Leo Pharma INC. | $63.63 | 2022 | |
| Pfizer INC. | $48.04 | 2023-2024 | |
| Galderma Laboratories, L.P. | $41.24 | 2019-2024 | |
| Genzyme Corporation | $38.82 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $23.14 | 2022 | |
| Biofrontera INC. | $22.11 | 2024 | Ameluz, Rhodoled Xl, Xepi |
| Merz North America, INC. | $21.11 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.47 | 2019 | |
| Incyte Corporation | $15.44 | 2021 | |
| Pierre Fabre Pharmaceuticals, INC. | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lamont Hornbeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.